In-depth review: Coronarography.AI

395 words · Editorial

Coronarography.AI positions itself at the intersection of accessible screening and clinical caution. Developed by cardiologist Timur Pulatovich Abdualimov, this application uses a neural network to predict coronary artery pathology from a standard ECG image and a short set of risk factors. Its core value proposition is speed and simplicity: a sub-second analysis that outputs a prediction for occlusion, subocclusion, or stenosis of the main coronary arteries. For a cardiologist or general practitioner, this tool functions as a preliminary triage layer, not a diagnostic endpoint. The dual-input design—combining the ECG trace with patient-reported risk factors such as obesity, smoking, or hypertension—is a thoughtful nod to the multifactorial nature of coronary artery disease. But the accuracy metrics demand a sober read. With a sensitivity of 63%, the tool will miss a meaningful number of true positives, which is a critical limitation in any screening context where false negatives carry high risk. The specificity of 88% is more reassuring, but the AUC of 0.74 places it in the moderate discrimination range. In practice, this means a positive result warrants follow-up, but a negative result does not fully rule out disease. The tool is best understood as a non-invasive, remote-capable risk stratification aid, especially valuable in settings where access to a cardiologist or conventional angiography is limited. For the individual user concerned about heart health, the app offers a data point, but the developer's own FAQ underscores that a positive result should prompt a specialist consultation. The ECG requirement—any single-page image, ideally at 25 mm/sec—keeps the barrier low, but the neural network's training scope is limited to the main coronary arteries, not the entire vascular tree. Emergency departments might find it useful for rapid initial assessment of chest pain patients, but the moderate sensitivity means it cannot replace clinical judgment or standard protocols. Overall, Coronarography.AI is a niche tool that fits best into a workflow where speed and non-invasiveness are prioritized over absolute diagnostic certainty. Its real-world utility will depend on how well clinicians integrate it as one input among many, rather than as a standalone decision-maker. The app is free to use, which lowers the adoption barrier, but the lack of published peer-reviewed validation beyond the developer's own claims may give some practitioners pause. For now, it is a promising but cautious addition to the cardiology AI landscape, best suited for early detection and triage in resource-constrained environments.

Who it's built for

Cardiologists
Why it fits
Provides a rapid, non-invasive screening adjunct to help triage patients before deciding on invasive angiography. The sub-second analysis fits into busy workflows.
Best value
Quickly rule in high-risk patients for further testing, potentially reducing unnecessary angiograms.
Caution
Moderate sensitivity (63%) means some pathology may be missed; should not replace clinical judgment or definitive imaging.
General practitioners
Why it fits
Enables primary care physicians to assess coronary risk with minimal equipment—just an ECG image and risk factor questionnaire.
Best value
Identifies patients needing urgent cardiology referral, especially in settings without immediate specialist access.
Caution
Positive results require specialist follow-up; false positives may cause unnecessary anxiety.
Individuals concerned about their heart health
Why it fits
Offers a simple self-assessment tool to understand how lifestyle factors (obesity, smoking) impact coronary health.
Best value
Provides immediate feedback and motivation to consult a doctor if results are concerning.
Caution
Self-diagnosis is not advised; results are not a substitute for professional medical evaluation.
Healthcare providers in remote areas
Why it fits
Brings AI-driven coronary screening to locations with limited access to cardiologists and angiography equipment.
Best value
Enables early detection and triage, potentially reducing time to treatment for acute conditions.
Caution
Internet access and ECG machine required; accuracy may vary with image quality.

Key features

AI-Powered Prediction of Coronary Artery Pathology
A neural network analyzes ECG images and risk factors to predict occlusion, subocclusion, and stenosis of main coronary arteries.
Benefit
Provides a non-invasive, rapid risk assessment that can guide clinical decisions and prioritize patients for invasive testing.
Limitation
Predicts only main coronary artery pathology; does not assess microvascular disease or other cardiac conditions.
Analysis Based on ECG Images and Risk Factors
Combines a standard 12-lead ECG image with patient risk factors (e.g., obesity, smoking) to improve prediction accuracy.
Benefit
Leverages readily available clinical data, making it easy to integrate into existing workflows without additional tests.
Limitation
Requires a clear ECG image at 25 mm/sec; poor quality images may reduce accuracy.
Immediate Results
Processes input and returns a prediction in less than one second.
Benefit
Enables real-time decision-making in acute settings, such as emergency departments or primary care consultations.
Limitation
Speed does not compensate for moderate sensitivity; results should be interpreted with caution.
Identification of Occlusion, Subocclusion, and Stenosis
Detects specific types of coronary artery blockages: complete occlusion, near-complete subocclusion, and partial stenosis.
Benefit
Helps differentiate severity of coronary artery disease, aiding in treatment urgency stratification.
Limitation
Does not quantify degree of stenosis or provide anatomical details like angiography.
Accuracy Metrics: Sensitivity, Specificity, AUC
Reported sensitivity 63%, specificity 88%, AUC 0.74 for predicting main coronary artery damage.
Benefit
High specificity reduces false positives, making positive results reasonably reliable for triggering further action.
Limitation
Low sensitivity means many true positives are missed; negative result does not rule out disease.

Real-world use cases

Predicting Impact of Lifestyle Changes on Coronary Health
Health-conscious individual
1. Scenario
  An individual who is obese and smokes wants to understand their coronary risk. They upload an ECG and input risk factors into the app.
2. Solution
  The AI analyzes the ECG and risk factors, providing a prediction of myocardial ischemia or coronary pathology.
3. Outcome
  The user receives immediate feedback on their current risk status, which can motivate lifestyle changes and prompt a doctor visit.
Early Detection for Prompt Specialist Consultation
General practitioner
1. Scenario
  A general practitioner sees a patient with atypical chest pain and no immediate access to a cardiologist. The GP uses the app during the visit.
2. Solution
  The app analyzes the patient's ECG and risk factors, returning a positive result for possible coronary artery pathology.
3. Outcome
  The GP can refer the patient urgently to a cardiologist, potentially catching acute coronary syndrome early.
Remote Non-Invasive Coronary Angiography
Healthcare provider in remote area
1. Scenario
  A rural clinic with no cardiologist uses the app to screen patients with cardiac symptoms before deciding on transfer to a city hospital.
2. Solution
  Staff upload ECG images and risk factors; the app provides a prediction within seconds.
3. Outcome
  Helps prioritize limited resources and reduce unnecessary transfers, while identifying high-risk patients who need immediate angiography.
Triage in Emergency Departments
Emergency physician
1. Scenario
  An emergency physician sees multiple chest pain patients and needs to quickly identify those with high likelihood of coronary occlusion.
2. Solution
  The physician uses the app as an adjunct to standard ECG interpretation, getting a sub-second prediction.
3. Outcome
  Supports rapid triage decisions, potentially accelerating time to catheterization lab activation for positive cases.

Pros & cons

Pros

Non-invasive technique
Fast results (less than a second)
Remote accessibility
Early identification of acute conditions
Does not require extensive computer resources or expensive equipment

Cons

Sensitivity of 63% may result in false negatives
Requires an ECG image
Requires user input of risk factors

Frequently asked questions

How accurate is Coronarography.AI?General

The neural network predicts damage to the main coronary arteries with a sensitivity of 63%, specificity of 88%, and AUC of 0.74. This means it correctly identifies about 63% of actual cases (moderate sensitivity) and correctly rules out 88% of non-cases (good specificity). It is a useful screening tool but not definitive; negative results do not guarantee absence of disease.

What ECG image format is required?Workflow

Any standard 12-lead ECG image on one page is acceptable. It is recommended that the recording speed be 25 mm/sec for optimal analysis. The image should be clear and well-lit to ensure accurate processing.

Is Coronarography.AI a replacement for traditional angiography?Limitations

No. Coronarography.AI is a non-invasive screening tool that predicts the likelihood of coronary artery pathology. It is not a substitute for invasive coronary angiography, which remains the gold standard for definitive diagnosis and treatment planning. Positive results require confirmation with further testing.

What should I do if the result is positive?Workflow

If you receive a positive result, you should contact a specialist (cardiologist) for further evaluation. Additional tests such as stress testing, CT angiography, or invasive coronary angiography may be needed to confirm the findings and determine appropriate treatment.

Who developed Coronarography.AI?General

The application was developed by cardiologist Timur Pulatovich Abdualimov. It is designed to leverage neural network analysis for early detection of coronary heart disease.

Is the app free to use?Pricing

Based on available information, Coronarography.AI appears to be free to use. There are no pricing details listed on the website. However, users should verify current pricing or any future changes on the official site.

Browse all